The Respective Roles of Controlled Clinical Trials and Cohort Monitoring Studies in the Pre- and Postmarketing Assessment of Drugs

Author： Vray Muriel  

Publisher： Adis International

ISSN： 0040-5957

Source： Therapie, Vol.60, Iss.4, 2005-01, pp. : 345-349

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Fragility Index in a Cohort of Pediatric Randomized Controlled Trials

By Matics Travis J.   Khan Nadia   Jani Priti   Kane Jason M.  

Journal of Clinical Medicine, Vol. 6, Iss. 8, 2017-08 ,pp. : 79-79

MDPI

Access to resources Recommend Favorite

New anti-epileptic drugs: overcoming the limits of randomised controlled trials

By Brigo Francesco  

International Journal of Evidence-based Healthcare, Vol. 9, Iss. 4, 2011-12 ,pp. : 440-443

Blackwell Publishing

Access to resources Recommend Favorite

Randomised controlled trials from the critical care literature: identification and assessment of quality

By Langham J   Thompson E   Rowan K  

Clinical Intensive Care, Vol. 13, Iss. 2-3, 2002-09 ,pp. : 73-83

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Management of Painful Symptoms with Duloxetine: A Review of the Efficacy in Pre-Clinical and Clinical Studies

By  

Current Drug Therapy, Vol. 6, Iss. 2, 2011-05 ,pp. : 121-136

Bentham Science Publishers

Access to resources Recommend Favorite

The Results of Major Clinical Trials: Critical Assessment, the Circulation of Information and Media Coverage

By Fouchard Marie  

Therapie, Vol. 59, Iss. 3, 2004-01 ,pp. : 323-328

Adis International

Access to resources Recommend Favorite